Yazar "Özet, Ahmet" için listeleme
-
Antiangiogenic therapy in ovarian cancer for whom and when?
Bilgetekin, İrem; Çetin, Bülent; Özet, Ahmet (Medical Communications, 2017)Tumor angiogenesis appears to be an important process in epithelial ovarian cancer development. Bevacizumab is a monoclonal antibody that can neutralize vascular endothelial growth factor, a promoter of the initiation phase ... -
Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme
Çetin, Bülent; Gönül, İpek Işık; Gumusay, Özge; Bilgetekin, İrem; Algın, Efnan; Özet, Ahmet; Üner, Aytuğ (Wiley, 2018)The identification of prognostic factors in patients with glioblastoma multiforme (GBM) represents an area of increasing interest. Carbonic anhydrase IX (CA-IX), a hypoxia marker, correlates with tumor progression in a ... -
Classic Kaposi's sarcoma: A review of 156 cases
Çetin, Bülent; Aktaş, Bilge; Bal, Öznur; Algın, Efnan; Akman, Tülay; Koral, Lokman; Kaplan, Mehmet Ali; Demirci, Umut; Uncu, Doğan; Özet, Ahmet (Elsevier Taiwan, 2018)Background: Kaposi's sarcoma (KS) is a reactive, multifocal, multicentric, angiogenic neoplastic proliferation that is thought to originate from endothelial cells that are infected with human herpesvirus-8 (HHV-8). This ... -
Hepatotoxicity of vascular endothelial growth factor receptor tyrosine kinase inhibitors: clinical practice and evidence
Çetin, Bülent; Bilgetekin, İrem; Cengiz, Mustafa; Özet, Ahmet (Springer International Publishing, 2017)Vascular endothelial growth factor (VEGF) plays an important role in the growth of tumor cells, and in their invasion, metastasis, and angiogenesis. Kinase inhibitors (which are taken orally, work intracellularly, and can ... -
HER2/neu as target in gastric adenocarcinoma
Çetin, Bülent; Özet, Ahmet (Ame Publ Co, 2016)Gastric adenocarcinoma (GAC), a heterogeneous disease characterized by epidemiologic and histopathologic differences across countries, is a leading cause of cancer-related death. -
Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy
Karaçin, Cengiz; Eren, Tülay; Zeynelgil, Esra; İmamoğlu, Göksen İnanç; Altınbaş, Mustafa; Karadağ, İbrahim; Başal, Fatma Buğdaycı; Bilgetekin, İrem; Sütçüoğlu, Osman; Yazıcı, Ozan; Özdemir, Nuriye; Özet, Ahmet; Yıldız, Yeşim; Esen, Selin Aktürk; Uçar, Gökhan; Uncu, Doğan; Dinç, Bedia; Aykan, Musa Barış; Ertürk, İsmail; Karadurmuş, Nuri; Civelek, Burak; Çelik, İsmail; Ergun, Yakup; Doğan, Mutlu; Öksüzoğlu, Ömür Berna (Future Medicine Ltd, 2021)Aim: To evaluate the immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. Methods: This multicenter, prospective, observational study was conducted with 47 patients ... -
Intravascular large B-cell lymphoma of the gallbladder
Intravascular large B-cell lymphoma (IVLBCL) is a rare type of extranodal B-cell lymphoma characterized by the growth of lymphoma cells within the lumina of small vessels. Two major patterns of clinical presentation ... -
Managing synchronous liver metastases in colorectal cancer
Çetin, Bülent; Bilgetekin, İrem; Cengiz, Mustafa; Özet, Ahmet (Springer India, 2018)The most common site of blood-borne metastases from colorectal cancers (CRC) is the liver. Resection of (liver) metastases is a part of standard treatment of metastatic colorectal cancer. Hepatic resection is the first-line ... -
Pazopanib-induced hepatotoxicity in an experimental rat model
Çetin, Bülent; Yılmaz, Güldal Esendağlı; Armağan, Berkan; Afşar, Barış; Demirci, Umut; Gülbahar, Özlem; Gümüşsoy, Özge; Bilgetekin, İrem; Özet, Ahmet; Üner, Aytuğ (Karger, 2018)Pazopanib is an effective treatment for advanced renal cell carcinoma and soft tissue sarcoma. Besides classical adverse events of this drug class, hepatotoxicity has been described as a frequent side effect. the aim of ... -
The potential for chemotherapy-free strategies in advanced prostate cancer
Çetin, Bülent; Özet, Ahmet (S. Karger AG, 2019)The treatment landscape for advanced prostate cancer is evolving rapidly, with new agents and strategies, and more optimal use of existing therapies under constant development. Efforts were focused on better understanding ...
